MedPath

Effect Of Katankateryadi Kwatha And Shuddha Shilajit In The Management Of Type 2 Diabetes Mellitus

Phase 2
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2024/07/070254
Lead Sponsor
Ayurvedic and Unani Tibbia College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of either sex aged between 30 to 65 years.

If yes in any two of the four:

2.Blood sugar –fasting 7.0 – 8.4 mmol/L or ( 125-150mg/dl)

PP – 11.0 – 13.8 mmol/l or( 199-250 mg/dl.)

Glycosylated Hemoglobin (HbA1c) 6.4% - 7.5%

Subjects having classical symptoms of diabetes with random glucose levels =200mg/dl (=250mg/dl)

3.Subjects who are able to come for follow up on fixed visits and are well aware about the treatment plan.(only type 2 DM patients)

4.Subjects willing to participate and able to provide written informed consent.

Exclusion Criteria

1.Patient suffering from the complications of Diabetes Mellitus like diabetic neuropathy, diabetic retinopathy etc. which require an urgent treatment.

2.patients on any other AYUSH medication for glucose control. Uncontrolled hypertensive subjects(BP with or without medication 140/90 mmHg after 5 min. of rest)

3.patients having any antidiabetic medicine of any other pathy in the last 3 months.

4.patients with any Heart disease or known cases of MI, unstable angina or CHF.

5.patients with current or past diagnosis of malignancy (any malignancy diagnosis in last five years)

6.patients who have a recent history or who are currently known to abuse of alcohol or drugs.

7.patients suffering from major systemic illness necessitating long term drug treatment (rheumatoid arthritis, psycho-neuro-endocrinal disorders,TB, AIDS etc).

8.patients who have completed participation in any other clinical trail during the past six (06 months).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath